Catalyst OrthoScience

Executive Summary

Catalyst OrthoScience is a privately-held medical device company dedicated to developing bone-preserving shoulder arthroplasty systems. Founded in 2015 and headquartered in Naples, Florida, the company focuses on anatomically correct implants that enable less invasive surgery, faster recovery, and improved range of motion. Its portfolio includes total, reverse, and fracture shoulder systems designed for both hospital and ambulatory surgery center (ASC) settings. By prioritizing bone preservation and minimally invasive techniques, Catalyst aims to address the growing demand for outpatient shoulder procedures and differentiated implants that improve patient outcomes. The company's innovative approach positions it to capture share in the expanding shoulder arthroplasty market, driven by an aging population and increasing preference for ASC-based surgeries. With its private status, Catalyst may be pursuing strategic partnerships or funding to accelerate commercialization and expand its product pipeline.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) Clearance for Next-Generation Reverse Shoulder System70% success
• TBDPublication of Pivotal Clinical Trial Results for Total Shoulder System60% success
• Q3 2026Strategic Partnership with Major ASC Network50% success